Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Invested Capital (2019 - 2025)

10x Genomics' Return on Invested Capital history spans 7 years, with the latest figure at 0.08% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 19.0% year-over-year to 0.08%; the TTM value through Dec 2025 reached 0.08%, up 19.0%, while the annual FY2025 figure was 0.09%, 19.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.08% at 10x Genomics, up from 0.12% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.07% in Q4 2021 and bottomed at 0.71% in Q1 2021.
  • The 5-year median for Return on Invested Capital is 0.24% (2025), against an average of 0.29%.
  • The largest YoY upside for Return on Invested Capital was 62bps in 2021 against a maximum downside of -60bps in 2021.
  • A 5-year view of Return on Invested Capital shows it stood at 0.07% in 2021, then crashed by -211bps to 0.22% in 2022, then tumbled by -68bps to 0.37% in 2023, then increased by 24bps to 0.28% in 2024, then skyrocketed by 70bps to 0.08% in 2025.
  • Per Business Quant, the three most recent readings for TXG's Return on Invested Capital are 0.08% (Q4 2025), 0.12% (Q3 2025), and 0.14% (Q2 2025).